Moon Haeng Hur

Clinical Assistant Professor

Seoul National University Hospital

South Korea

Research Interests

Explore related searches

Professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Moon Haeng Hur is a Clinical Assistant Professor at Seoul National University Hospital in South Korea. His research areas focus on hepatocellular carcinoma management, diabetes-related liver conditions, and the application of machine learning in predicting liver health outcomes. Recent publications include studies on the impact of medical-policy conflicts on Hepatocellular carcinoma, the efficacy of diabetes medications, and the development of predictive models utilizing AI and imaging biomarkers.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (6)

Eun Ju Cho

SOUTH KOREA

View details

Sehoon Park

SOUTH KOREA

View details

Jeong-Hoon Lee

Professor

Seoul National University Hospital

SOUTH KOREA

View details

Goh Eun Chung

SOUTH KOREA

View details

Hyunjae Shin

Clinical Assistant Professor

National Cancer Center

SOUTH KOREA

View details

SUNG WON CHUNG

Clinical Assistant Professor

Asan Medical Center

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Moon Haeng Hur

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis

Impact of the 2024 medical-policy conflict on hepatocellular carcinoma management in Korea

Comparison of the Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Patients with Steatotic Liver Disease

AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis B

A machine learning model to predict liver-related outcomes after the functional cure of chronic hepatitis B

Extrahepatic malignancies and antiviral drugs for chronic hepatitis B: A nationwide cohort study

Inhibition of sodium-glucose cotransporter-2 and liver-related complications in individuals with diabetes: a Mendelian randomization and population-based cohort study

Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis

Comparison of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis

Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B.

Collaborators (6)

Eun Ju Cho

Sehoon Park

Jeong-Hoon Lee

Goh Eun Chung

Hyunjae Shin

SUNG WON CHUNG

Make your next move.